Skip to main content

Prostatic Hyperplasia, Benign (BPH)

Michael T. Partin, MD and Sahel Uddin, DO Reviewed 04/2024
 


BASICS

  • Benign prostatic hyperplasia (BPH) is due to proliferation of both smooth muscle and epithelial cell lines of the periurethral prostate which causes increased prostate volume and may lead to co...

DIAGNOSIS

HISTORY

  • Screen for other causes such as infection, procedural history, or neurogenic causes

  • Evaluate symptom severity with the American Urological Association Society Symptom Index (AUA-SI) or...

TREATMENT

GENERAL MEASURES

  • Treatment ranges from watchful waiting to lifestyle modifications, medications, or surgical management.

  • Mild symptoms (score of <7) or moderate symptoms (score 8-15) on IPS...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

  • DRE and PSA yearly in patients who choose watchful waiting; PSA should not be checked while patient is in retention, recently catheterized, or w...

REFERENCES

1
McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–1803.
2
Pearson R, Williams PM. Common question...

SEE ALSO

CODES

ICD10

  • N40.0 Enlarged prostate without lower urinary tract symptoms

  • N40.1 Enlarged prostate with lower urinary tract symptoms

SNOMED

  • 266569009 Benign prostatic hyperplasia (disorder)

  • 444808002 Benign ...

CLINICAL PEARLS

  • Although medical therapy has changed the management of BPH, it has only delayed the need for TURP by 10-15 years, not eliminated it.

  • Urinary retention, obstructive uropathy, recurrent U...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

×